Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment.

Autor: Londres HD; Julio Trigo Hospital, Havana, Cuba., Armada JJ; Salvador Allende Hospital, Havana, Cuba., Martínez AH; Julio Trigo Hospital, Havana, Cuba., Abdo Cuza AA; Medical & Surgical Research Center (CIMEQ), Havana, Cuba., Sánchez YH; Salvador Allende Hospital, Havana, Cuba., Rodríguez AG; Salvador Allende Hospital, Havana, Cuba., Figueroa SS; Julio Trigo Hospital, Havana, Cuba., Llanez Gregorich EM; Julio Trigo Hospital, Havana, Cuba., Torres Lahera ML; Julio Trigo Hospital, Havana, Cuba., Peire FG; Medical & Surgical Research Center (CIMEQ), Havana, Cuba., González TM; Luis Díaz Soto Hospital, Havana, Cuba., González YZ; National Institute of Hematology & Immunology, Havana, Cuba., Añé Kouri AL; Center of Molecular Immunology (CIM), Havana, Cuba., Palomo AG; Center of Molecular Immunology (CIM), Havana, Cuba., Concepción MT; Center of Molecular Immunology (CIM), Havana, Cuba., Pérez LM; Center of Molecular Immunology (CIM), Havana, Cuba., Luaces-Alvarez PL; Center of Molecular Immunology (CIM), Havana, Cuba., Iglesias DE; Center of Molecular Immunology (CIM), Havana, Cuba., Hernández DS; Center of Molecular Immunology (CIM), Havana, Cuba., Suzarte MR; Center of Molecular Immunology (CIM), Havana, Cuba., Ramos TC; Center of Molecular Immunology (CIM), Havana, Cuba.

Publikováno v: Immunotherapy [Immunotherapy] 2022 May; Vol. 14 (7), pp. 521-530. Date of Electronic Publication: 2022 Mar 21.

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection.

Autor: Engler, Melanie, Albers, Dan, Von Maltitz, Pascal, Groß, Rüdiger, Münch, Jan, Cirstea, Ion Cristian

Publikováno v: Life Science Alliance; Sep2023, Vol. 6 Issue 9, p1-14, 14p